glp-1 cardiovascular benefit Effects of Glucagon-Like Peptide-1 Receptor Agonists Mechanisms by which GLP-1 agonists

GLP-1 receptor agonists are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Semaglutide Linked to 3x Risk of Stomach Paralysis An October 2023, study published in the Journal of the American Medical Association (JAMA) revealed that Ozempic and other semaglutide users face a threefold increased risk of stomach paralysis compared to those on oral weight loss drugs

For Wegovy, cite the SELECT trial (20% reduction in major cardiovascular events)

Certain doses of Zepbound, for example, are available in single-dose vials or multi-dose KwikPens , which can be a less expensive option compared to the autoinjector pens for those who are paying out of pocket